Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee-Reference-Cited by-同舟云学术

Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee

Published:2023-10 Issue: Volume: Page:
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Robb Kevin P.,Galipeau Jacques^ORCID,Shi Yufang,Schuster Michael,Martin Ivan^ORCID,Viswanathan Sowmya

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference44 articles.

1. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities;Galipeau;Cell Stem Cell,2018

2. Mesenchymal stem cell perspective: cell biology to clinical progress;Pittenger;NPJ Regen Med,2019

3. The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?;Galipeau;Cytotherapy,2013

4. Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses;Costa;Cell Mol Life Sci,2021

5. Mesoblast Limited. Mesoblast resubmits biologic license application (BLA) to FDA for remestemcel-l in children with steroid-refractory acute graft versus host disease (SR-aGVHD). https://investorsmedia.mesoblast.com/static-files/60aa26a8-85ce-4735-8fa6-2b0769eb6120; 2023 [accessed 9.8.23].

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioengineering MSCs for untapped therapeutic potential;Immunotherapy;2024-09-13

2. Comparative single-cell transcriptional and proteomic atlas of clinical-grade injectable mesenchymal source tissues;Science Advances;2024-07-12

3. Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design;Extracellular Vesicles and Circulating Nucleic Acids;2024-07-05

4. Elucidation of the key therapeutic targets and potential mechanisms of Andrographolide multi-targets against osteoarthritis via network pharmacological analysis and experimental validation;Gene;2024-06

5. Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options;International Journal of Molecular Sciences;2024-05-31